Missing data

Missing data

Author: The BMJ August 27, 2013 Duration: 23:25

The problem of missing data is well known, especially in cases where drug companies conceal evidence. However pharmaceutical industry misconduct is not the only cause, and a cluster of papers in this week's BMJ show how aspects of the culture of medical science contribute to the problem.

Elizabeth Loder, BMJ's clinical editor, talks to Harlan Krumholz (Harold H Hines Jr professor of medicine at Yale University) and Joseph Ross (assistant professor of medicine, also at Yale) about missing data from US publicly funded trials. Lisa Bero (professor at the Department of Clinical Pharmacy, University of California) describes how adding missing data to meta-analyses of drug trials can change the results, and Richard Riley (senior lecturer in medical statistics at Birmingham University) explains why individual participant meta-analyses aren't as balanced as we may think.


Produced by The BMJ, this weekly audio series delves into the pivotal research and urgent clinical debates shaping modern medicine. Each episode moves beyond the published page, bringing together the authors, critics, and practitioners directly involved to dissect a new study or a pressing health question. The conversation is rigorous and nuanced, designed for those who appreciate the complexity behind headlines. You’ll hear unscripted discussion about methodology, implications for practice, and the occasional healthy disagreement that drives science forward. This isn't just a summary of the latest findings; it's a critical appraisal in real time, offering listeners a front-row seat to the evolving discourse that defines evidence-based care. The Medicine and Science from The BMJ podcast serves as an essential audio companion for clinicians, academics, and anyone keen to understand the ‘why’ and ‘how’ behind medical news. It transforms the latest evidence from the journal into an accessible, thought-provoking dialogue, ensuring that busy professionals can stay deeply informed. Tune in for a direct, intelligent, and often surprising take on the science that matters most.
Author: Language: English Episodes: 1000

Medicine and Science from The BMJ
Podcast Episodes
Ray Moynihan - Declarations of interest in healthcare leaders [not-audio_url] [/not-audio_url]

Duration: 21:48
*Non covid content alert* While the last couple of months have been covid-19 focused, the work of the beforetimes carries on - including a topic the BMJ is perennially interested in, industry funding of medics. Ray Moyni…
Wellbeing – how to write a wellbeing prescription [not-audio_url] [/not-audio_url]

Duration: 27:36
How might stress affect your performance as a healthcare worker? That’s the question that Mark Stacey, a consultant obstetric anaesthetist in Cardiff, has been interested in for the past 10 years. He saw similarities in…
Talking about dying from covid with Scott Murray and Katherine Shear [not-audio_url] [/not-audio_url]

Duration: 54:40
With COVID-19 still ongoing, and at the forefront of the minds of doctors, patients and members of the public alike, difficult conversations are taking place - GPs are encouraged to talk about death with those who might…
Pandemics from history - how they inform our response now [not-audio_url] [/not-audio_url]

Duration: 23:07
Does history count as a non-pharmaceutical intervention? Much of our view on what to do in this pandemic has been influenced by the 1917 Spanish 'flu outbreak - even though covid-19 seems to be acting differently. In thi…
Adam Kucharski, using viral epidemiology to combat fake news [not-audio_url] [/not-audio_url]

Duration: 15:55
Hydroxychloroquine is in the news again - as Trump and some news organisations are pushing it as a treatment, despite evidence (published in The BMJ) showing it lacks efficacy, and has a load of potential negative effect…
Talk evidence covid-19 update - answering questions with big data [not-audio_url] [/not-audio_url]

Duration: 38:24
Big data is being crunched to help us tackle some of the enormous amount of uncertainty about covid-19, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing. In these podcasts, we're goin…